TH 588

Discontinued Product

5334 has been discontinued.

View all MTH1 products.
说明: Potent MTH1 inhibitor
化学名: N4-Cyclopropyl-6-(2,3-dichlorophenyl)-2,4-pyrimidinediamine
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (3)

生物活性 for TH 588

TH 588 is a potent MTH1 inhibitor (IC50 = 5 nM). Induces oxidative DNA damage and reduces survival in cancer cells. Inhibits growth of breast and colorectal cancer xenografts in mice.

许可信息

Sold under license from Thomas Helleday's Foundation for Medical Research and Oxcia AB.

技术数据 for TH 588

分子量 295.17
公式 C13H12Cl2N4
储存 Store at -20°C
纯度 ≥98% (HPLC)
CAS Number 1609960-31-7
PubChem ID 73389731
InChI Key PNMYJIOQIAEYQL-UHFFFAOYSA-N
Smiles NC1=NC(C2=C(Cl)C(Cl)=CC=C2)=CC(NC3CC3)=N1

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

参考文献 for TH 588

参考文献是支持产品生物活性的出版物。

Gad et al (2014) MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool. Nature 508 215 PMID: 24695224

按标靶查看相关产品

按产品操作查看相关产品

查看全部 MTH1 Inhibitors

关键词: TH 588, TH 588 supplier, TH588, MTH1, MutT, homolog-1, inhibitors, inhibits, potent, NUDT1, (MTH1), 5334, Tocris Bioscience

篇 TH 588 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 TH 588 的引用文献。

TH 588 的评论

目前没有该产品的评论。 Be the first to review TH 588 and earn rewards!

Have you used TH 588?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Cancer Metabolism Research Product Guide

Cancer Metabolism Research Product Guide

This product guide reviews some of the main areas in cancer metabolism research and lists around 150 products that can be used to investigate metabolic pathways in cancer including:

Cancer Metabolism Poster

Cancer Metabolism Poster

This poster summarizes the main metabolic pathways in cancer cells and highlights potential targets for cancer therapeutics. Genetic changes and epigenetic modifications in cancer cells alter the regulation of cellular metabolic pathways providing potential cancer therapeutic targets.

Epigenetics in Cancer Poster

Epigenetics in Cancer Poster

This poster summarizes the main epigenetic targets in cancer. The dysregulation of epigenetic modifications has been shown to result in oncogenesis and cancer progression. Unlike genetic mutations, epigenetic alterations are considered to be reversible and thus make promising therapeutic targets.